Below please find a table outlining a discounted cash flow forecast for AXR, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Amrep Corp ranked in the 19th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 72.67%. In terms of the factors that were most noteworthy in this DCF analysis for AXR, they are:
The company's compound free cash flow growth rate over the past 4.98 years comes in at -0.08%; that's greater than only 18.44% of US stocks we're applying DCF forecasting to.
As a business, AXR is generating more cash flow than only 2.42% of positive cash flow stocks in the Real Estate.
The business' balance sheet reveals debt to be 3% of the company's capital (with equity being the remaining amount). Approximately only 9.49% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Amrep Corp? See LTC, UHT, BDN, HASI, and PGRE.